EFFICIENCY OF APPLICATION OF COMPLEX TOPICAL DRUGS IN PATIENTS WITH INFLAMMATORY DISEASES OF THE PHARYNX
https://doi.org/10.21518/2079-701X-2017-8-24-28
Abstract
Infectious-inflammatory diseases of the pharynx are the most common pathological processes in the human population. Correct diagnosis and rational choice of effective treatment are directly correlate with important role of the pharyngeal tube in the life of the organism and a high risk of complications. The vast majority of clinical cases do not require the use of systemic drugs, topical therapy only. However, in the light of new data on the importance of microbial populations (microbiome), working as a functional barrier between the environment and nasopharyngeal mucosa, attention is attracted to topical antiseptics with antiinflammatory and biocenose saving effects, as part of complex therapy in diseases of the throat In the light of this issue, topical drugs based on lysozyme an enzyme, which is a natural antiseptic for the human body, are looking promising. These products are represented by Lysobact® (Bosnalijek, Bosnia and Hercegovina). It has proven anti-inflammatory, immunomodulatory and antiseptic action, and it`s efficacy is meaningful in treatment of the pharynx diseases in patients of different age groups.
About the Authors
G. N. Nikiforova
First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Russian Federation
MD, Prof.
V. M. Svistushkin
First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Russian Federation
MD, Prof.
D. B. Bidanova
First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Russian Federation
K. B. Volkova
First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Russian Federation
References
1. Рязанцев С.В., Кочеровец В.И. Этиопатогенетическая терапия заболеваний верхних дыхательных путей и уха. Методические рекомендации. СПб., 2008. 98 с.
2. Дифференциальная диагностика и лечение острого тонзиллфарингита. Клинические рекомендации. Москва. http://glav-otolar.ru/wp-content/uploads/2015/02/КР-О. Тонзиллофарингит-утвержденный.doc. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008911.pub2/full.
3. Пальчун В.Т. и др. Оториноларингология: национальное руководство. Под ред. В.Т. Пальчуна. М.: ГЭОТАР-Медиа, 2008. 960 с.
4. Туровский А.Б., Талалайко Ю.В. Медикаментозная терапия острых воспалительных заболеваний глотки. РМЖ, 2011, 24: 1501-1505.
5. Никифорова Г.Н., Золотова А.В., Свистушкин М.В. Боль в глотке: причины возникновения и способы лечения. Фарматека: к конгрессу «Человек и лекарство», 2015, 6: 25-29.
6. ESCMID Sore Throat Guideline Group. Guideline for the management of acute sore throat. Clin Microbiol Infect., 2012 Apr, 18.
7. Vicedomini D, Lalinga G, Lugli N, D’Avino A. Diagnosis and management of acute pharyngotonsillitis in the primary care pediatrician’s office. Minerva Pediatr, 2014 Feb, 66(1): 69-76.
8. Быкова В.П., Сатдыкова Г.П. Морфофункциональная организация лимфоэпителиальных органов глотки человека. Известия АН. Серия биологическая, 2002, 4: 463-471.
9. Арефьева Н.А. Тонзиллярная патология. Современное состояние проблемы. Вестник оториноларингологии, 2012, 6: 10-13.
10. Юлиш Е.И. Факторы местного иммунитета при респираторных инфекциях и методы их активации. Здоровье ребенка, 2010, 5: 63-67.
11. Cots JM, Alós JI, Bárcena M, Boleda X, Cañada JL, Gómez N, Mendoza A, Vilaseca I, Llor C. Recommendations for management of acute pharyngitis in adults. Enferm Infecc Microbiol Clin, 2016 Nov, 34(9): 585-594.
12. Gwaltney JM. In: Mandell G. L, Bennet J. E., Dolin R. eds. Principles and practice of infectious diseases. New York, 1995.
13. Dajani R, Zove S, Taft P. Lisozime secretion by submucoasal glands protects the airway from bacterial. Ann. J. Res. Cell Mol. Biol., 2005, 32(6): 548-552.
14. Инструкция к медицинскому применению препарата Лизобакт. http://lisobact.ru/.
15. Chernyshov AV, Melnicov OF. Tonsillar lymphocyte subsets in tonsillitis and hyperplasia. 7th Internat Congress of Mucosal Immunology (Prague, Czechoslovakia, August 16-20, 1992). Abstr. Prague, 1992, 41.
16. Погорелова О.О., Усенко Д.В., Ардатская М.Д., Дикая А.В., Горелов А.В. Оценка эффективности Лизобакта в лечении острых респираторных заболеваний у детей. Инфекционные болезни, 2009, 7(1): 69–72.
Review
For citations:
Nikiforova GN, Svistushkin VM, Bidanova DB, Volkova KB. EFFICIENCY OF APPLICATION OF COMPLEX TOPICAL DRUGS IN PATIENTS WITH INFLAMMATORY DISEASES OF THE PHARYNX. Meditsinskiy sovet = Medical Council. 2017;(8):24-28. (In Russ.) https://doi.org/10.21518/2079-701X-2017-8-24-28
Views:
6190
Email this article 